Physician profile
Jacob C Townsend
NPI 1003932955
$51,968.90
in general payments reported to CMS, 2019-2025
40 companies · $7,943 in 2025
The $7,943 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $8,681 · 2021: $9,809 · 2022: $8,052 · 2023: $1,423 · 2024: $1,372 · 2025: $7,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Food and Beverage: $3,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Food and Beverage | $3,237.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $44,401.15 | 2019-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Cardiovascular Systems INC. | $2,035.99 | 2019-2023 | Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $1,520.27 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $599.74 | 2022-2025 | |
| Edwards Lifesciences Corporation | $316.75 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $221.19 | 2022-2025 | |
| Abbott Laboratories | $208.31 | 2021-2025 | Cardiomems, Jeti Peripheral Catheter |
| Amgen INC. | $200.27 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $178.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $176.13 | 2019-2025 | Camzyos, Eliquis |
| Bard Peripheral Vascular, INC. | $174.69 | 2022-2023 | Venclose Maven Catheter |
| Merck Sharp & Dohme LLC | $168.50 | 2021-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.27 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $139.71 | 2019-2023 | |
| Terumo Medical Corporation | $132.94 | 2019-2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $130.60 | 2023-2024 | Venaseal, Abre, In.Pact Admiral |
| Organogenesis INC. | $117.51 | 2022 | |
| Baxter Healthcare | $117.39 | 2020 | |
| Janssen Pharmaceuticals, INC | $115.09 | 2019-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $111.82 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.75 | 2019-2025 | Lifevest |
| Veryan Medical Incorporated | $94.74 | 2020 | |
| Boston Scientific Corporation | $80.65 | 2020-2025 | Varithena Administration Pack, Watchman Flx |
| Inari Medical, INC. | $69.09 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $60.52 | 2019-2025 | Farxiga, Lokelma |
| Kiniksa Pharmaceuticals International, Plc | $42.18 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $39.61 | 2022-2024 | Uptravi, Opsumit |
| Biosense Webster, INC. | $37.73 | 2025 | Carto 3 |
| Alnylam Pharmaceuticals INC. | $31.55 | 2024-2025 | Amvuttra |
| Atricure, INC. | $29.25 | 2023 | |
| Esperion Therapeutics, INC. | $21.55 | 2021 | |
| Lundbeck LLC | $20.48 | 2019 | |
| Abbvie INC. | $20.39 | 2019 | |
| Angiodynamics, INC. | $19.92 | 2019 | |
| Bridgebio Pharma, INC. | $18.06 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $17.29 | 2024 | |
| Medtronic Vascular, INC. | $14.36 | 2020 | |
| Amarin Pharma, INC. | $13.53 | 2019 | |
| Cook Medical LLC | $13.53 | 2019 | |
| Penumbra, INC. | $13.08 | 2024 | Penumbra System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Townsend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.